Aethlon Medical Inc.

1.38+0.0100+0.73%Vol 195.42K1Y Perf -76.50%
Jun 5th, 2020 16:00 DELAYED
BID1.36 ASK1.40
Open1.35 Previous Close1.37
Pre-Market- After-Market1.38
 -1.37 -100.00%  - -%
Target Price
13.00 
Analyst Rating
— 0.00
Potential %
842.03 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★     47.14
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap12.92M 
Earnings Rating
Neutral
Price Range Ratio 52W %
7.48 
Earnings Date
6th Jul 2020

Today's Price Range

1.331.40

52W Range

0.76409.00

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-6.12%
1 Month
0.73%
3 Months
-42.50%
6 Months
-47.53%
1 Year
-76.50%
3 Years
-94.65%
5 Years
-98.81%
10 Years
-99.39%

TickerPriceChg.Chg.%
AEMD1.380.01000.73
AAPL331.509.18002.85
GOOG1 438.3926.21001.86
MSFT187.204.28002.34
XOM53.083.98008.11
WFC31.671.45004.80
JNJ147.300.57000.39
FB230.774.48001.98
GE7.880.14001.81
JPM111.234.79004.50
Mngmt EffectivenessValueIndustryS&P 500US Markets
ROE (5Y Avg)
-1 139.64
ROE last 12 Months
-172.52
ROA (5Y Avg)
-128.57
ROA last 12 Months
-129.41
ROC (5Y Avg)
-218.37
ROC last 12 Months
-145.97
Return on invested Capital Q
-36.95
Return on invested Capital Y
-113.97
Assets Turnover
0.00
Receivables Turnover
3.20
Financial StrengthValueIndustryS&P 500US Markets
5.30
5.30
0.02
0.04
-56.00
Leverage Ratio 1.70
ProfitabilityValueIndustryS&P 500US Markets
-
-1 171.40
-1 167.20
-2 329.90
-
RevenueValueIndustryS&P 500US Markets
443.46K
0.05
0.02
-21.30
Earnings HistoryEstimateReportedSurprise %
Q03 2020-1.03-0.2872.82
Q02 2020-1.10-1.29-17.27
Q01 2020-1.20-1.65-37.50
Q04 2019-1.20-1.35-12.50
Q03 2019-1.05-1.65-57.14
Q02 2019-1.05-1.20-14.29
Q01 2019-1.20-0.9025.00
Q04 2018-0.10-0.0640.00
Earnings Per EndEstimateRevision %Trend
3/2020 QR-0.16--
3/2020 QR-0.950.00-
3/2020 FY-3.37--
3/2021 FY-0.51--
Next Report Date6th Jul 2020
Estimated EPS Next Report-0.16
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume195.42K
Shares Outstanding9.37M
Trades Count625
Dollar Volume260.11K
Avg. Volume1.43M
Avg. Weekly Volume284.42K
Avg. Monthly Volume441.30K
Avg. Quarterly Volume468.79K

Aethlon Medical Inc. (NASDAQ: AEMD) stock closed at 1.38 per share at the end of the most recent trading day (a 0.73% change compared to the prior day closing price) with a volume of 218.72K shares and market capitalization of 12.92M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 6 people. Aethlon Medical Inc. CEO is Timothy C. Rodell.

The one-year performance of Aethlon Medical Inc. stock is -76.5%, while year-to-date (YTD) performance is 43.3%. AEMD stock has a five-year performance of -98.81%. Its 52-week range is between 0.764 and 9, which gives AEMD stock a 52-week price range ratio of 7.48%

Aethlon Medical Inc. currently has a PE ratio of -, a price-to-book (PB) ratio of 3.50, a price-to-sale (PS) ratio of 31.04, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -129.41%, a ROC of -145.97% and a ROE of -172.52%. The company’s profit margin is -%, its EBITDA margin is -1 167.20%, and its revenue ttm is $443.46 Thousand , which makes it $0.05 revenue per share.

Of the last four earnings reports from Aethlon Medical Inc., there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.16 for the next earnings report. Aethlon Medical Inc.’s next earnings report date is 06th Jul 2020.

The consensus rating of Wall Street analysts for Aethlon Medical Inc. is (0), with a target price of $13, which is +842.03% compared to the current price. The earnings rating for Aethlon Medical Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Aethlon Medical Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Aethlon Medical Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 20.87, ATR14 : 0.14, CCI20 : 35.48, Chaikin Money Flow : 0.10, MACD : 0.00, Money Flow Index : 67.05, ROC : 7.81, RSI : 49.57, STOCH (14,3) : 27.73, STOCH RSI : 0.05, UO : 52.92, Williams %R : -72.27), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Aethlon Medical Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Summary Rating--Strong Buy
1.00

Aethlon Medical Inc.

Aethlon Medical Inc is a medical technology company. It is focused on addressing unmet needs in health and biodefense. The company operates through two segments namely Aethlon for therapeutic applications, which represents its therapeutic business activities and ESI for diagnostic applications which signifies diagnostic business activities. It is focused on the development of Hemopurifier which is a clinical-stage therapeutic device that eliminates life-threatening viruses from the circulatory system of infected individuals. The company generates revenue from government contracts.

CEO: Timothy C. Rodell

Teplephone: +1 858 459-7800

Address: 9635 Granite Ridge Drive, San Diego 92123, CA, USA

Number of employees: 6

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

50%50%

Bearish Bullish

57%43%

Bearish Bullish

57%43%

News

Stocktwits